Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India.
J Neurol Sci. 2010 Sep 15;296(1-2):34-8. doi: 10.1016/j.jns.2010.06.013. Epub 2010 Jul 3.
Stroke is a complex disease caused by combination of multiple risk factors. Recent findings have suggested that stroke has a significant genetic component. Various types of genetic polymorphisms have been suggested to contribute to the risk of stroke. Gene polymorphisms of renin-angiontensin aldosterone system (RAAS) have been suggested to be risk factors for hypertension, cardiovascular diseases and stroke. In the present case-control study we investigated the association of -344C/T (rs1799998) [corrected] polymorphism in the promoter region of the human aldosterone (CYP11B2) gene with genetic predisposition to hypertension, ischemic stroke and stroke subtypes classified according to TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification. Four hundred and three stroke patients (hypertensives:normotensives=219:184) and three hundred and ninety four, sex and age matched healthy controls (hypertensives:normotensives=118:276) were involved in the study. The region of interest in the CYP11B2 gene was amplified by polymerase chain reaction and genotypes determined by subjecting the PCR products to restriction digestion by the enzyme HaeIII. Significant difference was observed in the genotypic distribution and allelic frequency between the stroke patients and healthy controls. TT genotype and T allele associated significantly with hypertension and stroke (p<0.000 in hypertension and p=0.000 in case of stroke). A stepwise logistic regression analysis confirmed these findings. To establish that this polymorphism is associated with stroke independent of hypertension, we compared stroke patients without hypertension with normotensive controls. Significant difference was observed in genotypic distribution and allelic frequency between the two groups (p=0.000). Further evaluating the association of this polymorphism with stroke subtypes we found significant associations with intracranial large artery atherosclerosis, lacunar stroke and cardioembolic stroke (p=0.000 in each case). In conclusion our study suggests that -344T allele of CYP11B2 gene is an important risk factor for hypertension and ischemic stroke. However, this is a preliminary study and the results need to be confirmed in a larger cohort.
中风是一种由多种危险因素共同作用引起的复杂疾病。最近的研究结果表明,中风具有显著的遗传成分。各种类型的基因多态性被认为是中风的风险因素。肾素-血管紧张素-醛固酮系统(RAAS)的基因多态性被认为是高血压、心血管疾病和中风的危险因素。在本病例对照研究中,我们研究了人类醛固酮(CYP11B2)基因启动子区域的-344C/T(rs1799998)[更正]多态性与高血压、缺血性中风以及根据 TOAST(急性中风治疗试验中的 Org 10172)分类的中风亚型之间的遗传易感性的关系。研究纳入了 403 名中风患者(高血压:正常血压=219:184)和 394 名性别和年龄匹配的健康对照者(高血压:正常血压=118:276)。通过聚合酶链反应扩增 CYP11B2 基因的目标区域,并通过将 PCR 产物用 HaeIII 酶进行限制性消化来确定基因型。在中风患者和健康对照组之间,观察到基因型分布和等位基因频率存在显著差异。TT 基因型和 T 等位基因与高血压和中风显著相关(高血压 p<0.000,中风 p=0.000)。逐步逻辑回归分析证实了这些发现。为了确定这种多态性与高血压无关,我们比较了没有高血压的中风患者与正常血压对照者。两组间基因型分布和等位基因频率存在显著差异(p=0.000)。进一步评估这种多态性与中风亚型的关系,我们发现与颅内大动脉粥样硬化、腔隙性中风和心源性栓塞性中风之间存在显著关联(每种情况 p=0.000)。总之,我们的研究表明,CYP11B2 基因的-344T 等位基因是高血压和缺血性中风的重要危险因素。然而,这是一项初步研究,结果需要在更大的队列中得到证实。